Abstract
Objective: Free radical scavenging and/or inhibition of free radical generation may be a therapeutically useful property of sulfhydryl (SH)-containing angiotensin converting enzyme (ACE) inhibitors. In vitro studies on the anti-free radical activity of captopril, an SH-containing ACE inhibitor, brought conflicting results. The purpose of this study was to assess the antioxidant effects of captopril in the clinical setting of myocardial infarction.
Patients and Methods: 63 patients with acute myocardial infarction who entered the International Study on Infarct Survival-4 were randomised to receive oral captopril (50mg twice daily) or placebo. Plasma lipid peroxides (measured as thiobarbituric acid-reactive substances) and free radical production by isolated leucocytes (measured by chemiluminescence) were determined before the start of the study treatment and on days 7 and 14 of captopril/placebo.
Results: The values of plasma lipid peroxides and leucocyte free radical production were not altered by captopril treatment. Initial values of lipid peroxides (mean, nmol/L × ml−1) were 3.6 in the placebo group, 3.8 in the captopril group, and increased to 4.5 and 4.9 (day 7) and to 4.3 and 4.7 (day 14), respectively, showing no significant differences between the groups. Furthermore, leucocyte chemiluminescence in the placebo and captopril groups showed no significant changes from baseline either on day 7 or on day 14.
Conclusions: The results of the present study do not provide support for the antioxidant properties of captopril in the clinical setting of myocardial infarction.
Similar content being viewed by others
References
Ertl G, Kloner RA, Alexander W, et al. Limitation of experimental infarct size by an angiotensin-converting enzyme inhibitor. Circulation 1982; 65: 40–8
Woodward B, Zakaria M. Effect of some free radical scavengers on reperfusion-induced arrhythmias in the isolated rat heart. J Mol Cell Cardiol 1985; 17: 485–93
Goldschmidt JE, Tallarida RJ. Pharmacological evidence that captopril possesses an endothelium-mediated component of vasodilation: effect of sulfhydryl groups on endothelium-derived relaxing factor. J Pharmacol Exp Ther 1991; 257: 1136–45
Westlin W, Mullane K. Does captopril attenuate reperfusion-induced myocardial dysfunction by scavenging free radicals? Circulation 1988; 77 (6 Pt 2): 130–9
Martin MFR, Surrall KE, McKenna F, et al. Captopril: a new treatment for rheumatoid arthritis? Lancet 1984; 1: 1325–7
Bagchi D, Prasad R, Das DK. Direct scavenging of free radicals by captopril, an angiotensin converting enzyme inhibitor. Biochem Biophys Res Comm 1989; 158: 52–7
Chopra M, McMurray J, Stewart J, et al. Free radical scavenging: a potentially beneficial action of thiol-containing angiotensin converting enzyme inhibitors. Biochem Soc Trans 1990; 18: 1184–5
Noda Y, Mori A, Packer L. Free radical scavenging properties of alacepril metabolites and lisinopril. Res Commun Mol Pathol Pharmacol 1997; 96(2): 125–36
Weglicki WB, Mak IT, Simic MG. Mechanisms of cardiovascular drugs as antioxidants. J Mol Cell Cardiol 1987; 22: 1199–1208
Kukreja RC, Kontos HA, Hess ML. Captopril and enalaprilat do not scavenge the Superoxide anion. Am J Cardiol 1990; 65: 24I–7I
Mehta JL, Nicolini FA, Lawson DL. Sulfhydryl group in angiotensin converting enzyme inhibitors and Superoxide radical formation. J Cardiovasc Pharmacol 1990; 16: 847–9
Sogaard P, Klausen IC, Rungby J, et al. Lipoprotein(a) and oxygen free radicals in survivors of acute myocardial infarction: effects of captopril. Cardiology 1996; 87: 18–22
ISIS-4 Collaboration Group. A randomized factorial trial assessing early oral captopril, oral mononitrate and intravenous magnesium sulphate in 58050 patients with suspected acute myocardial infarction. Lancet 1995; 345: 669–85
Buege J, Aust S. Microsomal lipid peroxidation. In: Fleisher S, Packer L, editors. Methods in enzymology. Vol. 52. New York: Academic Press, 1978: 302–10
Herbaczynska-Cedro K, Wartanowicz M, Panczenko-Kresowska B, et al. Inhibitory effect of vitamins C and E on the oxygen free radical production in human polymorphonuclear leukocytes. Eur J Clin Invest 1994; 24: 316–9
Herbaczynska-Cedro K, Klosiewicz-Wasek B, Cedro K, et al. Supplementation with vitamins C and E suppresses leukocyte oxygen free radical production in patients with myocardial infarction. Eur Heart J 1995; 16: 1044–9
Draper HH, Squires EJ, Mahmoodi H, et al. A comparative evaluation of thiobarbituric acid methods for the determination of malondialdehyde in biological materials. Free Radic Biol Med 1993; 15:353–63
Kostner K, Hornykewycz S, Yang P, et al. Is oxidative stress causally linked to unstable angina pectoris? A study in 100 CAD patients and matched controls. Cardiovasc Res 1997; 36: 330–6
Schimke I, Kahl PE, Romaniuk P, et al. Konzentration Thiobarbitursaure-reaktiver Substanzen (TBARS) in Serum nach Myokardinfarkt. Klin Wochenschr 1986; 64: 1237–9
Giardina B, Penco M, Lazzarino G, et al. Effectiveness of thrombolysis is associated with a time-dependent increase of malondialdehyde in peripheral blood of patients with acute myocardial infarction. Am J Cardiol 1993; 71: 787–93
Bridges AB, McNeill GP, Pringle TH, et al. A late increase in free radical activity post myocardial infarction. Eur Heart J 1995; 16: 899–902
Chopra M, Beswick H, Clapperton M, et al. Antioxidant effects of angiotensin-converting enzyme (ACE) inhibitors: free radical and oxidant scavenging are sulfhydryl dependent but lipid peroxidation is inhibited by both sulfhydryl- and non-sulfhydryl-containing ACE inhibitors. J Cardiovasc Pharmacol 1992; 19: 330–40
Wayner DDM, Burton GW, Ingold KU, et al. The relative contributions of vitamin E, urate, ascorbate and proteins to the total peroxyl radical-trapping antioxidant activity of human blood plasma. Biochim Biophys Act 1987; 924: 408–19
Acknowledgements
The authors are indebted to Professor Rory Collins for his valuable comments. We are grateful to Dr Bogna Kresowska for the measurements of lipid peroxides and to Mrs Ewa Buszko for her expert secretarial assistance. Funding was provided by the Postgraduate Medical School, Warsaw, Poland.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Herbaczynska-Cedro, K., Klosiewicz-Wasek, B. Captopril Does Not Influence the Components of Free Radical Activity Following Acute Myocardial Infarction. Clin. Drug Investig. 19, 441–445 (2000). https://doi.org/10.2165/00044011-200019060-00006
Published:
Issue Date:
DOI: https://doi.org/10.2165/00044011-200019060-00006